Great Valley Advisor Group, Inc. Biocryst Pharmaceuticals Inc Transaction History
Great Valley Advisor Group, Inc.
- $3.84 Billion
- Q3 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 16,400 shares of BCRX stock, worth $122,836. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,400
Previous 16,400
-0.0%
Holding current value
$122,836
Previous $101,000
22.77%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$149 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$88.9 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$68 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$66.3 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.39B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...